Evaluating the Potential ???Economic Attractiveness??? of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating the Potential ???Economic Attractiveness??? of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome

Published:2000-03 Issue:3 Volume:17 Page:263-272
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Eisenstein Eric L.,Peterson Eric D.,Jollis James G.,Tardiff Barbara E.,Califf Robert M.,Knight J. David,Mark Daniel B.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Reference22 articles.

1. International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable Angina

2. A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina

3. Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

4. Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

5. Use and Misuse of the Term “Cost Effective” in Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes;Clinical Therapeutics;2013-08

2. Nonfatal myocardial infarction and long-term outcomes in coronary artery disease;American Heart Journal;2012-01

3. An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event;The European Journal of Health Economics;2008-04-30

4. Costs for Heart Failure With Normal vs Reduced Ejection Fraction;Archives of Internal Medicine;2006-01-09

5. Decision models for assessing the cost effectiveness of drug-eluting stents;Expert Opinion on Pharmacotherapy;2005-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3